Skip to main content
OpenTrials

Clinical trial condition

Systemic Inflammatory Response Syndrome

Explore clinical trials studying Systemic Inflammatory Response Syndrome. Study availability and eligibility vary by location and protocol.

2,295 public trials 327 recruiting studies
Refine in advanced search Browse all conditions

Systemic Inflammatory Response Syndrome trial results

Completed

TriVerity in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis

NCT04094818

Conditions
Brain Diseases, Central Nervous System Diseases, Encephalitis, +21 more
Locations
  • University of South Alabama Mobile, Alabama, United States
  • University of Southern California Los Angeles, California, United States
  • University of California Davis Medical Center Sacramento, California, United States
  • Medstar Health Research Institute Washington D.C., District of Columbia, United States
View all 26 locations
View Trial Details
Completed

Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults

NCT04882085

Conditions
Acute Pyelonephritis, Bacteremia, Bacterial Infections, +27 more
Locations
  • The First Affiliated Hospital of Bengbu Medical Bengbu, Anhui, China
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • Chizhou People's Hospital Chizhou, Anhui, China
  • Fuyang People's Hospital Fuyang, Anhui, China
View all 37 locations
View Trial Details
Completed

Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

NCT00285259

Conditions
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +37 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • University of South Florida Tampa, Florida, United States
View all 22 locations
View Trial Details
Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of 3 Doses of MOTREM (Nangibotide) in Patients With Septic Shock

NCT03158948

Conditions
Infections, Inflammation, Pathologic Processes, +5 more
Locations
  • Cliniques Universitaires Saint-Luc (there may be other sites in this country) Brussels, Belgium
  • Inserm Clinical Investigational Center, CHU Dupuytren (there may be other sites in this country) Limoges, France
  • Radboudumc (there may be other sites in this country) Nijmegen, Netherlands
  • Hospital Clínico San Carlos, Medicina Intensiva (there may be other sites in this country) Madrid, Spain
View Trial Details
Completed

Feasibility of 5% Albumin Compared With Balanced Crystalloid, as Intravenous Fluid Resuscitation in Adult Patients With Sepsis, Presenting as an Emergency to Hospital

NCT04540094

Conditions
Infections, Inflammation, Pathologic Processes, +3 more
Locations
  • Aberdeen Royal Infirmary Aberdeen, United Kingdom
  • Addenbrookes Hospital Cambridge, United Kingdom
  • Derby Teaching Hosptial NHS Foundation Trust Derby, United Kingdom
  • Royal Infirmary Edinburgh Edinburgh, United Kingdom
View all 15 locations
View Trial Details

Related conditions